← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1998Last known activity
Jun 30, 2025
Timeline
1950s
- Jan 1, 1958
RTI International— Founded
Drugs by trial phase (53 distinct, 51 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (21 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alcoholism
- Anemia, Sickle Cell
- Arterial Occlusive Diseases
- Arteriosclerosis
- Birth Weight
- Body Weight
- Bronchopulmonary Dysplasia
- Cleft Lip
- Cleft Palate
- Cocaine-Related Disorders
- Coronary Artery Disease
- Coronary Disease
- Death
- Diabetes, Gestational
- Diabetes Mellitus
- Disease
- Eclampsia
- Enuresis
- Fecal Incontinence
- Heart Diseases
- HELLP Syndrome
- Hemorrhage
- Hypertension, Pulmonary
- Hypotension
- Infant, Newborn, Diseases
- Infections
- Intracranial Hemorrhages
- Ischemia
- Lung Diseases
- Malaria
- Marijuana Abuse
- Maternal Death
- Myocardial Ischemia
- Neonatal Sepsis
- Perinatal Death
- Postphlebitic Syndrome
- Postthrombotic Syndrome
- Pre-Eclampsia
- Pregnancy Complications, Infectious
- Premature Birth
- Puerperal Infection
- Pulmonary Valve Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Retinal Diseases
- Retinopathy of Prematurity
- Sepsis
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Telangiectasia, Hereditary Hemorrhagic
- Telangiectasis
- Thrombosis
- Toxemia
- Urinary Bladder, Overactive
- Urinary Incontinence
- Urinary Incontinence, Stress
- Urinary Incontinence, Urge
- Vascular Diseases
- Venous Thrombosis
Recent trials (50)
- NCT06723392CollaboratorPhase 1Jun 30, 2025
- NCT06855108OfficialPhase 3Jun 30, 2025
- NCT06855108CollaboratorPhase 3Jun 30, 2025
- NCT06580444CollaboratorPhase 2Oct 24, 2024
- NCT06335407CollaboratorPhase 1Oct 14, 2024
- NCT05898022CollaboratorPhase 4Aug 17, 2023
- NCT05886712Lead sponsorN/AJul 1, 2023
- NCT05590260CollaboratorPhase 3Jan 1, 2023
- NCT04827056CollaboratorPhase 1Nov 9, 2021
- NCT04987775CollaboratorPhase 2Oct 31, 2021
- NCT04927338CollaboratorPhase 2Sep 30, 2021
- NCT04360681CollaboratorPhase 2Aug 28, 2020
- NCT04171531Overall official - principal investigatorPhase 3Apr 30, 2020
- NCT04171531CollaboratorPhase 3Apr 30, 2020
- NCT04254627CollaboratorPhase 1Feb 28, 2020
Details
- Founded
- Research Triangle Park, NC, US Jan 1, 1958
- Last known activity
- Jun 30, 2025